Prostate Cancer Clinical Trial
Developing an Imaging-Based Tool to Identify Areas for Prostate Cancer Biopsy
Summary
The purpose of the proposed research is to test and validate a Risk Map decision-support system (DSS) for prostate cancer Magnetic Resonance Imaging (MRI) interpretation and identification of clinically significant tumor site(s).
Eligibility Criteria
Inclusion Criteria:
Patients with known or suspected prostate cancer who have been referred to the Department of Radiology at the University of Chicago Medical Center for a diagnostic MRI exam of the prostate, to be followed by an MRI-guided fusion biopsy of the prostate.
Written informed consent.
Exclusion Criteria:
Patients incapable of giving informed written consent;
Patients who cannot adhere to the experimental protocols for any reason, or have an inability to communicate with the researcher;
Patients with psychiatric disorders that affect their ability to consent for themselves will be excluded and not the entire population of patients with psychiatric disorders.
Prisoners;
Minor children (under the age of 18 years old).
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
How clear is this clinincal trial information?